Back to top
more

Organon & Co. (OGN)

(Delayed Data from NYSE)

$18.55 USD

18.55
2,049,747

+0.13 (0.71%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $18.54 -0.01 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 252)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for OGN

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Organon & Co falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 693 706 737 70 319
Receivables 1,744 1,475 1,382 1,360 1,474
Notes Receivable 0 0 0 0 0
Inventories 1,315 1,003 915 971 1,071
Other Current Assets 756 747 726 977 1,091
Total Current Assets 4,508 3,931 3,760 3,378 3,955
Net Property & Equipment 1,183 1,018 973 998 680
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 5,136 5,252 5,254 5,106 5,172
Deposits & Other Assets 1,231 754 694 438 741
Total Assets 12,058 10,955 10,681 9,920 10,548
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 1,314 1,132 1,382 294 258
Current Portion Long-Term Debt 9 8 9 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 1,389 1,188 1,021 752 807
Income Taxes Payable 206 184 185 288 242
Other Current Liabilities 0 0 0 1,150 34
Total Current Liabilities 2,918 2,512 2,597 2,484 1,341
Mortgages 0 0 0 0 0
Deferred Taxes/Income 47 19 4 128 139
Convertible Debt 0 0 0 0 0
Long-Term Debt 8,751 8,905 9,125 0 70
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 412 411 463 1,822 1,963
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 12,128 11,847 12,189 4,434 3,513
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 3 3 3 0 0
Capital Surplus 25 0 0 0 0
Retained Earnings 443 -331 -998 0 0
Other Equity -541 -564 -513 5,486 7,035
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity -70 -892 -1,508 5,486 7,035
Total Liabilities & Shareholder's Equity 12,058 10,955 10,681 9,920 10,548
Total Common Equity -70 -892 -1,508 5,486 7,035
Shares Outstanding 255.60 254.30 253.50 NA NA
Book Value Per Share -0.27 -3.51 -5.95 -0.05 -0.07

Fiscal Year End for Organon & Co falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 693 414 326 459
Receivables NA 1,744 1,648 1,672 1,445
Notes Receivable NA 0 0 0 0
Inventories NA 1,315 1,186 1,199 1,121
Other Current Assets NA 756 802 761 755
Total Current Assets NA 4,508 4,050 3,958 3,780
Net Property & Equipment NA 1,183 1,096 1,110 1,055
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 5,136 5,164 5,195 5,224
Deposits & Other Assets NA 1,231 702 716 704
Total Assets NA 12,058 11,012 10,979 10,763
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 1,314 1,067 1,115 996
Current Portion Long-Term Debt NA 9 8 8 8
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 1,389 1,255 1,101 1,150
Income Taxes Payable NA 206 161 163 192
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 2,918 2,491 2,387 2,346
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 47 43 32 30
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 8,751 8,646 8,722 8,703
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 421 393 421
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 12,128 11,601 11,534 11,500
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 3 3 3 3
Capital Surplus NA 25 0 0 0
Retained Earnings NA 443 -16 -25 -206
Other Equity NA -541 -576 -533 -534
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA -70 -589 -555 -737
Total Liabilities & Shareholder's Equity NA 12,058 11,012 10,979 10,763
Total Common Equity 0 -70 -589 -555 -737
Shares Outstanding 255.60 255.60 255.60 255.00 255.00
Book Value Per Share 0.00 -0.27 -2.30 -2.18 -2.89